- Campagne D.M.
- Einarson A.
Purchase one-time access:Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
One-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:Subscribe to European Journal of Obstetrics and Gynecology and Reproductive Biology
- Fact: antidepressants and anxiolytics are not safe during pregnancy.Eur J Obstet Gynecol Reprod Biol. 2007; 135: 145-148
- The safety of psychtopic drugs in pregnancy.MedGenMed. 2005; 5;7 (Review): 3
- Problems with maternal antidepressant treatment and neonatal outcomes study.Arch Gen Psychiatry. 2007; 64 (author reply 867–8): 866
- SSRIs and birth defects.Epidemiology. 2007; 18 (author reply 412–3): 410-411
- Selective serotonin reuptake inhibitor use in pregnancy and fetal outcomes.American Psychiatric Association Meeting, San Diego, California, USA2007
Einarson A, Pistelli A, Desantis M, Malm H, Paulus WD, Panchaud A, Kennedy D, Einarson TR, Koren G. Evaluation of the Risk of Congenital Cardiovascular Defects Associated With Use of Paroxetine During Pregnancy.Am J Psychiatry. 2008; Apr 1. [Epub ahead of print]
- Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations.Pharmacoepidemiol Drug Saf. 2007; 16: 1203-1210
Dennis CL, Ross LE, Grigoriadis S. Cochrane Database Syst Rev. 2007 Jul 18;(3):CD006309. Psychosocial and psychological interventions for treating antenatal depression.
- Disparities in rates of unintended pregnancy in the United States, 1994 and 2001.Perspect Sex Reprod Health. 2006; 38: 90-96
ScienceDirectAccess this article on ScienceDirect
- Author's response: Antidepressants and anxiolytics in pregnancy: The facts standEuropean Journal of Obstetrics and Gynecology and Reproductive BiologyVol. 171Issue 2
- PreviewThe reaction of Nurse Einarson and colleagues helps us to get the problem of antidepressants and anxiolytics use during pregnancy under closer scientific and ethical scrutiny. She apparently is a staunch defender of the use of SSRIs and similar medications and, with funds from their manufacturers, has participated in studies of the effects of possibly teratogenic antidepressants on pregnant women. None of these studies considered non-pharmacologic ways to treat depression or anxiety. Indeed, these studies found that malformations occurred twice or three times as often in the SSRI or venlafaxine groups compared to the non-teratogenic group.